XSTO
DEDI
Market cap52mUSD
Oct 09, Last price
54.50SEK
1D
0.93%
1Q
19.39%
Jan 2017
-24.83%
IPO
211.43%
Name
Dedicare AB (publ)
Chart & performance
P/E
15.75
P/S
0.36
EPS
3.46
Div yield, %
4.60%
Shrs. gr., 5y
0.54%
Rev. gr., 5y
10.45%
Revenues
1.45b
-15.40%
Net income
33m
-29.68%
CFO
64m
-20.77%
Dividend
May 07, 20261.75 SEK/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dedicare AB (publ) is a firm specializing in providing temporary personnel for the healthcare sector. Operating mainly across Sweden, Norway, Finland, and Denmark, the company recruits and places a diverse range of professionals, including physicians, nurses, social workers, and management staff, alongside other health and social services employees. They offer flexible staffing options, from single temporary placements to full teams for entire departments or operational units. Established in 1996, its main office is located in Stockholm, Sweden.
Key people
Chairman of the Board · since 2007
Anette Sandsjo
Chief Financial Officer · since 2024
Kasper Madsen
Chief Executive Officer - Denmark · since 2024
Lene Odegard
Chief Executive Officer - Norway · since 2024
Mattis Kjellin
Chief Information Officer · since 2018
Bard Kristiansen
Chief Executive Officer, Managing Director, Interim Chief Executive Officer - Sweden · since 2024
Director, Head of Human Resources · since 2023
Anders Boman
Independent Director · since 2024
Siri Nilssen
Independent Director · since 2023
Independent Director · since 2021
Dag Sundstrom
Independent Director · since 2020
Headquarters & legal address
Dalagatan 100
Stockholm, AB 113 43
SE
Stockholm, AB 113 43
SE
Previous name
Dedicare AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||